Pharmacokinetics Services Market 2027 | The Insight Partners

Pharmacokinetics Services Market to 2027 - Global Analysis and Forecasts By Drug Type (Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services)

Report Code: TIPRE00007438 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Pharmacokinetics (PK) is a branch of pharmacology that is dedicated to determine the fate of substances administered to a living organism. It describes how the body affects any specific chemical after administration through metabolic changes of substances in the body and the route of excretion of the metabolites of the drug. Pharmacokinetics is a study about how the organism affects a drug. The chemical property of pharmacokinetics are affected by the route of administration and the dose of an administered drug which may affect the absorption rate.

MARKET DYNAMICS

The pharmacokinetics services market is anticipated to grow the market by the implementation of PK services in the drug development process that is a driving factor to invest in the market. By handling various conference and exhibitions for the market, brought increasing awareness through the rise and owing demand in the market. However, due to high cost of systems and technologies and lack of innovation in electrophoresis equipment technology is restraining the market. Moreover, through strong research and development in activities it is anticipated to witness fastest growth.

MARKET SCOPE

The "Global Pharmacokinetics Services Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of pharmacokinetics services market with detailed market segmentation by drug type and geography. The global pharmacokinetics services market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pharmacokinetics services market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global pharmacokinetics services market is segmented on the basis of drug type. Based on drug type, the market is segmented into small molecules pharmacokinetics services and large molecules (biopharmaceuticals) pharmacokinetics services.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pharmacokinetics services market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pharmacokinetics services market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pharmacokinetics services market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pharmacokinetics services market in these regions.

MARKET PLAYERS


The reports cover key developments in the pharmacokinetics services market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from pharmacokinetics services market are anticipated to lucrative growth opportunities in the future with the rising demand for pharmacokinetics services market in the global market. Below mentioned is the list of few companies engaged in the pharmacokinetics services market.

The report also includes the profiles of key pharmacokinetics services market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Biologics Consulting Group, Inc.
  •  Certara, L.P.
  •  Eurofins Scientific, Inc.
  •  Evotec AG
  •  GVK Biosciences Private Limited(Gvk Power & Infrastructure)
  •  Pacific BioLabs
  •  Parexel International Corporation
  •  Product Development, LLC(Jaguar Holding Company I, LLC)
  •  SGS SA
  •  Shanghai Medicilon Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmacokinetics Services Market - By Drug Type
1.3.2 Pharmacokinetics Services Market - By Region
1.3.2.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PHARMACOKINETICS SERVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PHARMACOKINETICS SERVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PHARMACOKINETICS SERVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACOKINETICS SERVICES - GLOBAL MARKET OVERVIEW
6.2. PHARMACOKINETICS SERVICES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PHARMACOKINETICS SERVICES MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. SMALL MOLECULES PHARMACOKINETICS SERVICES
7.3.1. Overview
7.3.2. Small Molecules Pharmacokinetics Services Market Forecast and Analysis
7.4. LARGE MOLECULES (BIOPHARMACEUTICALS) PHARMACOKINETICS SERVICES
7.4.1. Overview
7.4.2. Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Market Forecast and Analysis
8. PHARMACOKINETICS SERVICES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Pharmacokinetics Services Market Overview
8.1.2 North America Pharmacokinetics Services Market Forecasts and Analysis
8.1.3 North America Pharmacokinetics Services Market Forecasts and Analysis - By Drug Type
8.1.4 North America Pharmacokinetics Services Market Forecasts and Analysis - By Countries
8.1.4.1 United States Pharmacokinetics Services Market
8.1.4.1.1 United States Pharmacokinetics Services Market by Drug Type
8.1.4.2 Canada Pharmacokinetics Services Market
8.1.4.2.1 Canada Pharmacokinetics Services Market by Drug Type
8.1.4.3 Mexico Pharmacokinetics Services Market
8.1.4.3.1 Mexico Pharmacokinetics Services Market by Drug Type
8.2. EUROPE
8.2.1 Europe Pharmacokinetics Services Market Overview
8.2.2 Europe Pharmacokinetics Services Market Forecasts and Analysis
8.2.3 Europe Pharmacokinetics Services Market Forecasts and Analysis - By Drug Type
8.2.4 Europe Pharmacokinetics Services Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Pharmacokinetics Services Market
8.2.4.1.1 Germany Pharmacokinetics Services Market by Drug Type
8.2.4.2 France Pharmacokinetics Services Market
8.2.4.2.1 France Pharmacokinetics Services Market by Drug Type
8.2.4.3 Italy Pharmacokinetics Services Market
8.2.4.3.1 Italy Pharmacokinetics Services Market by Drug Type
8.2.4.4 Spain Pharmacokinetics Services Market
8.2.4.4.1 Spain Pharmacokinetics Services Market by Drug Type
8.2.4.5 United Kingdom Pharmacokinetics Services Market
8.2.4.5.1 United Kingdom Pharmacokinetics Services Market by Drug Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Pharmacokinetics Services Market Overview
8.3.2 Asia-Pacific Pharmacokinetics Services Market Forecasts and Analysis
8.3.3 Asia-Pacific Pharmacokinetics Services Market Forecasts and Analysis - By Drug Type
8.3.4 Asia-Pacific Pharmacokinetics Services Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Pharmacokinetics Services Market
8.3.4.1.1 Australia Pharmacokinetics Services Market by Drug Type
8.3.4.2 China Pharmacokinetics Services Market
8.3.4.2.1 China Pharmacokinetics Services Market by Drug Type
8.3.4.3 India Pharmacokinetics Services Market
8.3.4.3.1 India Pharmacokinetics Services Market by Drug Type
8.3.4.4 Japan Pharmacokinetics Services Market
8.3.4.4.1 Japan Pharmacokinetics Services Market by Drug Type
8.3.4.5 South Korea Pharmacokinetics Services Market
8.3.4.5.1 South Korea Pharmacokinetics Services Market by Drug Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Pharmacokinetics Services Market Overview
8.4.2 Middle East and Africa Pharmacokinetics Services Market Forecasts and Analysis
8.4.3 Middle East and Africa Pharmacokinetics Services Market Forecasts and Analysis - By Drug Type
8.4.4 Middle East and Africa Pharmacokinetics Services Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Pharmacokinetics Services Market
8.4.4.1.1 South Africa Pharmacokinetics Services Market by Drug Type
8.4.4.2 Saudi Arabia Pharmacokinetics Services Market
8.4.4.2.1 Saudi Arabia Pharmacokinetics Services Market by Drug Type
8.4.4.3 U.A.E Pharmacokinetics Services Market
8.4.4.3.1 U.A.E Pharmacokinetics Services Market by Drug Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Pharmacokinetics Services Market Overview
8.5.2 South and Central America Pharmacokinetics Services Market Forecasts and Analysis
8.5.3 South and Central America Pharmacokinetics Services Market Forecasts and Analysis - By Drug Type
8.5.4 South and Central America Pharmacokinetics Services Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Pharmacokinetics Services Market
8.5.4.1.1 Brazil Pharmacokinetics Services Market by Drug Type
8.5.4.2 Argentina Pharmacokinetics Services Market
8.5.4.2.1 Argentina Pharmacokinetics Services Market by Drug Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

10. PHARMACOKINETICS SERVICES MARKET, KEY COMPANY PROFILES
10.1. BIOLOGICS CONSULTING GROUP, INC.
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. CERTARA, L.P.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. EUROFINS SCIENTIFIC, INC.
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. EVOTEC AG
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. GVK BIOSCIENCES PRIVATE LIMITED(GVK POWER AND INFRASTRUCTURE)
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. PACIFIC BIOLABS
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. PAREXEL INTERNATIONAL CORPORATION
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. PRODUCT DEVELOPMENT, LLC(JAGUAR HOLDING COMPANY I, LLC)
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SGS SA
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. SHANGHAI MEDICILON INC.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Biologics Consulting Group, Inc.
2. Certara, L.P.
3. Eurofins Scientific, Inc.
4. Evotec AG
5. GVK Biosciences Private Limited(Gvk Power & Infrastructure)
6. Pacific BioLabs
7. Parexel International Corporation
8. Product Development, LLC(Jaguar Holding Company I, LLC)
9. SGS SA
10. Shanghai Medicilon Inc.